Showing results (411-420 of 781) with videos related to

Sort By:
Pageof 79
The Journal of Chemical Physics|October 5, 2013
Phase transitions in human IgG solutionsYing Wang, Aleksey Lomakin, Ramil F Latypov, et al.
Seminars in Oncology|April 30, 2003
Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerationsSteven P Treon, Abigail Kelliher, Beverly Keele, et al.
British Journal of Haematology|July 8, 2011
Managing multiple myeloma: the emerging role of novel therapies and adapting combination treatment for higher risk settingsPaul G Richardson, Jacob Laubach, Constantine S Mitsiades, et al.
Blood|January 19, 2006
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cellsTeru Hideshima, Laurence Catley, Hiroshi Yasui, et al.
Oncology (Williston Park, N.Y.)|August 29, 2007
Novel therapeutic avenues in myeloma: changing the treatment paradigmJoanne Ghobrial, Irene M Ghobrial, Constantine Mitsiades, et al.
Cancer Research|September 17, 2005
A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cellsDharminder Chauhan, Guilan Li, Klaus Podar, et al.
Blood|April 14, 2005
Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myelomaNoopur Raje, Shaji Kumar, Teru Hideshima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2003
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based reviewTheresa Hahn, John R Wingard, Kenneth C Anderson, et al.
Blood|October 18, 2003
Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigensRoberto Bellucci, Catherine J Wu, Sabina Chiaretti, et al.
The Journal of Biological Chemistry|March 2, 2002
NF-kappa B as a therapeutic target in multiple myelomaTeru Hideshima, Dharminder Chauhan, Paul Richardson, et al.
Pageof 79